<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 3</issue_number>
<issue_period>2015 (July - September)</issue_period>
<title>ASO TITRE IN ACUTE RHEUMATIC FEVER/RHEUMATIC HEART DISEASE IN PEDIATRIC AGE GROUP </title>
<abstract>Rheumatic fever and rheumatic heart disease remain significant causes of cardiovascular disease and mortality, particularly in the developing countries. The identification of the first attack of rheumatic fever/carditis is of paramount importance to prevent further episodes and residual cardiac damage. In the present study, we report the significance of antistreptolysin-O (ASO) test in the diagnosis of RF and RHD. The study aimed to determine ASO titre in normal children &amp; in those with rheumatic fever. Blood samples of 200 children clinically diagnosed as ARF/RHD and of 100 normal children aged 5-15 years were screened for ASO antibodies by latex agglutination test. Seropositivity of ASO antibodies was 77% in ARF/ RHD cases and 21% in control children. A total of 41% ARF/RHD cases and 14% of control children showed an ASO titre of 200IU/ml. Seropositivity of ASO antibodies was slightly more in females than males in cases as well as control. It can be suggested from our study that ASO titre of  greaterThan 200IU/ml or above should be taken as a diagnostic titre in the pediatric age group of our geographic area.</abstract>
<authors>DR. D. M. KULKARNI, DR. S. A. BARDAPURKAR,DR. S. L. NILEKAR AND DR. V. L. KULKARNI</authors>
<keywords>ASO, ARF, RHD, Pediatrics</keywords>
<pages>102-106</pages>
</article>
</Journal>
